Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
250.78
+2.03 (+0.81%)
Streaming Delayed Price
Updated: 12:32 PM EDT, Aug 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,977,520
Open
252.94
Bid (Size)
250.67 (200)
Ask (Size)
250.90 (200)
Prev. Close
248.76
Today's Range
249.87 - 255.29
52wk Range
190.75 - 267.47
Shares Outstanding
N/A
Dividend Yield
2.76%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
August 12, 2026
News Provided by USA News Group on behalf of Conexeu Sciences Inc.
From
USA News Group
Via
GlobeNewswire
2 Reasons to Like ABBV and 1 to Stay Skeptical
August 12, 2026
AbbVie has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 9.7% to $249.64 per...
Via
StockStory
Topics
Stocks
Supply Chain
Performance
YTD
+9.4%
+9.4%
1 Month
+1.1%
+1.1%
3 Month
+20.3%
+20.3%
6 Month
+13.5%
+13.5%
1 Year
+26.3%
+26.3%
More News
Read More
AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026?
↗
August 11, 2026
Via
The Motley Fool
AbbVie (NYSE:ABBV) Shares Slip on Apogee Acquisition Despite In-Line Q2 Results
↗
July 31, 2026
Via
Chartmill
Pfizer vs AbbVie: What's the Better Dividend Stock for Investors in 2026?
↗
August 11, 2026
Via
The Motley Fool
Topics
Stocks
AbbVie Piles on $8 Billion in Debt for Its Apogee Deal -- Should Dividend Investors Worry?
↗
August 11, 2026
Via
The Motley Fool
Is AbbVie Stock a Buy After Posting Strong Q2 Earnings?
↗
August 10, 2026
Via
The Motley Fool
Vanguard Health Care ETF vs State Street XLV: Which ETF Is the Better Buy for Investors in 2026?
↗
August 08, 2026
Via
The Motley Fool
Topics
ETFs
Economy
MarketBeat Week in Review – 08/03 - 08/07
↗
August 08, 2026
Via
MarketBeat
Topics
Economy
Intellectual Property
AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?
↗
August 07, 2026
Via
The Motley Fool
Could 1 Tiny Biotech Topple Vertex Pharmaceuticals' Cystic Fibrosis Empire?
↗
August 07, 2026
Via
The Motley Fool
The 5 Most Interesting Analyst Questions From AbbVie’s Q2 Earnings Call
August 07, 2026
Via
StockStory
Topics
Earnings
3 Cash-Producing Stocks for Long-Term Investors
August 06, 2026
Via
StockStory
Topics
Energy
This Stock Keeps Raising Its Dividend No Matter What the Market Does -- and Wall Street Thinks It's a Buy Right Now
↗
August 05, 2026
Via
The Motley Fool
Topics
Intellectual Property
Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One
August 04, 2026
From
American News Group
Via
GlobeNewswire
AbbVie (ABBV) Q2 2026 Earnings Call Transcript
↗
August 03, 2026
Via
The Motley Fool
Topics
Earnings
Economy
The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
↗
August 03, 2026
Via
MarketBeat
Topics
Artificial Intelligence
ETFs
Stocks
AbbVie Quietly Solved Its Biggest Problem—Now What?
↗
August 02, 2026
Via
MarketBeat
Topics
Intellectual Property
ABBV Q2 Deep Dive: Immunology and Neuroscience Expansion Shape Outlook Amid Guidance Reset
August 01, 2026
Via
StockStory
Why AbbVie Stock Slumped Today
↗
July 31, 2026
Via
The Motley Fool
Topics
Earnings
Here's How Much $1000 Invested In AbbVie 5 Years Ago Would Be Worth Today
↗
July 31, 2026
Via
Benzinga
AbbVie Q2 Earnings Call Highlights
↗
July 31, 2026
Via
MarketBeat
Topics
ETFs
Earnings
AbbVie Stock Falls as Guidance Cut Overshadows Strong Q2 Earnings Beat
↗
July 31, 2026
Via
Benzinga
AbbVie’s (NYSE:ABBV) Q2 CY2026: Beats On Revenue
July 31, 2026
Via
StockStory
Get insights into the top movers in the S&P500 index of Friday's pre-market session.
↗
July 31, 2026
Via
Chartmill
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 250.78
When was AbbVie last traded?
The last trade of AbbVie was at 08/13/26 12:32 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.